Хромосомный анализ в диагностике и прогнозировании острого миелоидного лейкоза: современное состояние вопроса
Е. В. Флейшман, Sokova Oi, А. В. Попа · Клиническая онкогематология. Фундаментальные исследования и клиническая практика · 2010
Current literature review and authors recent results on clinical significance of chromosome abnormalities in acute myeloid leukemia (AML) are presented. We discuss various prognostic group classifications based on cytogenetic analysis performed at diagnosis. Discrepancies between different scientific teams in defining risk groups are noted. New molecular markers useful for precise relapse risk prediction in AML with both normal and abnormal karyotypes are discussed. The problem of uneven age distribution of chromosome abnormalities significant for AML prognosis is described and association of age and treatment outcome is considered. Karyotype evolution characteristic for AML relapse is discussed. The problem of minimal residual disease (MRD) monitoring is presented, and the opportunity to detect leukemia cells by chromosome markers found at diagnosis is considered.
Cited by 0 works.